XINTAI, SHANDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global pharmaceutical packaging ...

By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...

Tens of thousands of cholesterol medication bottles are being recalled nationwide due to manufacturing issues that could ...

The U.S. Food and Drug Administration started taking applications for its PreCheck pilot, a new effort to accelerate the ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...

Eli Lilly to build $3.5 billion Lehigh Valley complex as demand for weight loss drugs grows ...

The U.S. House of Representatives Committee on Energy and Commerce's Subcommittee on Health held a recent hearing titled "Made in America: Strengthening Domestic Manufacturing and the Health Care ...

President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some ...

It’s in line with President Donald Trump’s executive order in May to shift manufacturing of drugs to the US Read more at The Business Times.

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's competitive position.